Xeris pharmaceuticals reports second quarter 2020 financial results and corporate highlights

Xeris pharmaceuticals, inc. (nasdaq: xers), a specialty pharmaceutical company leveraging its novel formulation technology platforms to develop and co

KFS Ratings Summary

KFS Quant Ranking